New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices.
Saved in:
| Title: | New Anticancer Drugs: Reliably Assessing "Value" While Addressing High Prices. |
|---|---|
| Authors: | Stewart, David J.1,2,3 (AUTHOR) dstewart@toh.ca, Bradford, John-Peter3 (AUTHOR) gerald.batist@mcgill.ca, Sehdev, Sandeep1,2,3 (AUTHOR) pwheatleyprice@toh.ca, Ramsay, Tim2 (AUTHOR), Navani, Vishal4 (AUTHOR) vishal.navani@albertahealthservices.ca, Rawson, Nigel S. B.5,6 (AUTHOR) eastlakerg@gmail.com, Jiang, Di Maria7,8 (AUTHOR) di.jiang@uhn.ca, Gotfrit, Joanna1,2 (AUTHOR), Wheatley-Price, Paul1,2,3 (AUTHOR), Liu, Geoffrey7,8 (AUTHOR) geoffrey.liu@uhn.ca, Kaplan, Alan7,9 (AUTHOR) for4kids@gmail.com, Spadafora, Silvana10 (AUTHOR) spadaforas@sah.on.ca, Goodman, Shaun G.7,11 (AUTHOR) goodmans@chrc.net, Auer, Rebecca A. C.2,12 (AUTHOR), Batist, Gerald3,13 (AUTHOR) |
| Source: | Current Oncology. May2024, Vol. 31 Issue 5, p2453-2480. 28p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 11980052 |
|---|---|
| DOI: | 10.3390/curroncol31050184 |
